Brittany is the Lead Nuclear Medicine Technologist – Radionuclide Therapy at Peter MacCallum Cancer Centre. Her role oversees the Theranostic programs for both compassionate access and clinical trials; including treatment for Thyroid Cancer, Neuroendocrine Tumours, and Prostate Cancer. Brittany’s research interests are in radiopharmaceuticals for imaging and therapy, including participation in numerous Theranostic phase I – 3 clinical trials. Brittany actively participates nationally and internationally towards the education and training of nuclear medicine technologists in radionuclide therapy.